ClearCut Medical Ltd.
Providing intuitive real-time margin assessment in the OR, aiming at reducing repeat surgeries.
Providing intuitive real-time margin assessment in the OR, aiming at reducing repeat surgeries.
ClearCut Medical Ltd. is an Israeli medical device company founded in 2010, specializing in real-time tumor margin assessment technology for intra-operative use. The company's flagship product, the ClearCoast™ system, is a portable MRI scanner designed to assist in margin assessment during Breast Conserving Surgery. Their system has received the CE mark and is already being utilized in Europe, with plans for commercial use in the US pending FDA marketing authorization. The company has garnered significant attention, conducting multiple clinical studies in various countries and receiving a Series B investment from Previz Ventures in May 2015. ClearCut's innovative technology and strategic market approach make it a promising player in the Health Care and Medical Devices industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B - Clear | Unknown | 1 | Previz Ventures | 29 May 2015 |
No recent news or press coverage available for ClearCut Medical Ltd..
We care about your data, and we'd love to use cookies make your experience better.
